Asia Pacific Pharmaceutical announced that on July 21, Qiu Zhongxun, the company's actual controller, chairman and general manager, proposed that the company buy back the shares. The total amount of repurchase capital is not less than 10 million yuan and no more than 20 million yuan. The source is own funds and/or self-financing, and the implementation period is not more than 12 months from the date the board of directors reviews and approves the plan. The shares to be repurchased will be used for employee stock ownership plans or equity incentives. If not implemented within three years, the unused portion will be cancelled in accordance with law. The matter is subject to approval procedures, and there is uncertainty.

Asia Pacific Pharmaceutical announced that on July 21, Qiu Zhongxun, the company's actual controller, chairman and general manager, proposed that the company buy back the shares. The total amount of repurchase capital is not less than 10 million yuan and no more than 20 million yuan. The source is own funds and/or self-financing, and the implementation period is not more than 12 months from the date the board of directors reviews and approves the plan. The shares to be repurchased will be used for employee stock ownership plans or equity incentives. If not implemented within three years, the unused portion will be cancelled in accordance with law. The matter is subject to approval procedures, and there is uncertainty.